COVID-19: Vaccines and Therapeutics
A third and fourth dose of the Pfizer or Moderna COVID-19 vaccine provided additional protection to eligible adults, the CDC reported Friday.
Immunocompromised people age 12 and older experience fewer local and systemic reactions after receiving a COVID-19 mRNA booster than after the third primary dose, the Centers for Disease Control and Prevention reports. The findings are based on responses to CDC’s voluntary V-safe virtual health…
The Food and Drug Administration yesterday authorized the Novavax COVID-19 vaccine for emergency use in adults, as recommended last month by its vaccine advisory committee.
Children’s Hospital Colorado has kept families informed with up-to-date news, resources and expert clinical advice about COVID-19 and vaccines. The hospital recently partnered with the Colorado Department of Public Health and Environment to administer COVID-19 vaccines to children between 6 months…
The departments of Health and Human Services and Defense have secured 3.2 million doses of the Novavax COVID-19 vaccine to give to states, federal pharmacy partners and federally qualified health centers.
The FDA last week revised its Evusheld fact sheet for health care providers, recommending repeat dosing every six months if patients need ongoing protection.
The Living Learning Network’s pandemic reflection book showcases the defining moments of COVID-19 as told by the front lines.
The departments of Health and Human Services and Defense yesterday announced an agreement to purchase at least 105 million doses of a Pfizer omicron-specific COVID-19 vaccine for use this fall if the Food and Drug Administration authorizes and the Centers for Disease Control and Prevention…
The Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response and Food and Drug Administration this week extended the shelf life for certain refrigerated lots of the COVID-19 combination monoclonal antibody therapies REGEN-COV and Evusheld.
Seattle Children’s Hospital is taking a collaborative approach with parents to vaccinate very young children against COVID-19